Correlation Between Valneva SE and Ascendis Pharma
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Ascendis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Ascendis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Ascendis Pharma AS, you can compare the effects of market volatilities on Valneva SE and Ascendis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Ascendis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Ascendis Pharma.
Diversification Opportunities for Valneva SE and Ascendis Pharma
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Valneva and Ascendis is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Ascendis Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascendis Pharma AS and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Ascendis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascendis Pharma AS has no effect on the direction of Valneva SE i.e., Valneva SE and Ascendis Pharma go up and down completely randomly.
Pair Corralation between Valneva SE and Ascendis Pharma
Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Ascendis Pharma. In addition to that, Valneva SE is 1.11 times more volatile than Ascendis Pharma AS. It trades about -0.14 of its total potential returns per unit of risk. Ascendis Pharma AS is currently generating about 0.03 per unit of volatility. If you would invest 12,459 in Ascendis Pharma AS on September 13, 2024 and sell it today you would earn a total of 647.00 from holding Ascendis Pharma AS or generate 5.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Valneva SE ADR vs. Ascendis Pharma AS
Performance |
| Timeline |
| Valneva SE ADR |
| Ascendis Pharma AS |
Valneva SE and Ascendis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Valneva SE and Ascendis Pharma
The main advantage of trading using opposite Valneva SE and Ascendis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Ascendis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will offset losses from the drop in Ascendis Pharma's long position.| Valneva SE vs. NuCana PLC | Valneva SE vs. Sage Therapeutic | Valneva SE vs. Sellas Life Sciences | Valneva SE vs. Third Harmonic Bio |
| Ascendis Pharma vs. Apellis Pharmaceuticals | Ascendis Pharma vs. BeiGene | Ascendis Pharma vs. Akero Therapeutics | Ascendis Pharma vs. Blueprint Medicines Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |